Londinia Opportunities Analyses - 09/23/2021 (GMT) ABCELLERA BIOLOGICS INC. - 1H
-
USD
(-)
-
15 min delayed data - NASDAQ Stocks
| Type: | Stocks |
| Ticker: | ABCL |
| ISIN: | CA00288U1066 |
- U.S. Stocks
- Timeframe : 1H
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
89%
0%
11%
My opinion
Bullish above 21.29 USD
My targets
22.63 USD (+3.14%)
23.29 USD (+6.15%)
My analysis
The bullish trend is currently very strong on ABCELLERA BIOLOGICS INC.. As long as the price remains above the support at 21.29 USD, you could try to benefit from the boom. The first bullish objective is located at 22.63 USD. The bullish momentum would be boosted by a break in this resistance. Buyers would then use the next resistance located at 23.29 USD as an objective. Crossing it would then enable buyers to target 34.10 USD. Be careful, given the powerful bullish rally underway, excesses could lead to a possible correction in the short term. If this is the case, remember that trading against the trend may be riskier. It would seem more appropriate to wait for a signal indicating reversal of the trend.
In the very short term, the general bullish sentiment is confirmed by technical indicators. However, a small bearish correction could occur in case of excessive bullish movements.
Force
0
10
8.9
Analysis too old. There are no more charts available.
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
Additional analysis
Quotes
ABCELLERA BIOLOGICS INC. rating 21.94 USD. The price registered an increase of +2.81% on the session with the lowest point at 21.17 USD and the highest point at 22.09 USD. The deviation from the price is +3.64% for the low point and -0.68% for the high point.21.17
22.09
21.94
A study of price movements over other periods shows the following variations:
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Abnormal volumes on ABCELLERA BIOLOGICS INC. were detected by the Central Volumes scanner:
Abnormal volumes
Timeframe : 5 days
Abnormal volumes
Timeframe : 20 days
Technical
Technical analysis of ABCELLERA BIOLOGICS INC. in 1H shows a strongly overall bullish trend. The signals given by the moving averages are 92.86% bullish. This strong bullish trend is confirmed by the strong signals currently being given by short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
In fact, 16 technical indicators on 18 studied are currently positioned bullish. Caution: the Central Indicators scanner currently detects an excess:
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : 1 hour
Price is back over the pivot point
Type : Bullish
Timeframe : Weekly
No signals are given by Central Patterns, a market scanner specialised in chart patterns, resistances and supports.
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 17.71 | 19.73 | 21.29 | 21.94 | 22.63 | 23.29 | 34.10 |
| Change (%) | -19.28% | -10.07% | -2.96% | - | +3.14% | +6.15% | +55.42% |
| Change | -4.23 | -2.21 | -0.65 | - | +0.69 | +1.35 | +12.16 |
| Level | Major | Major | Minor | - | Intermediate | Minor | Intermediate |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 19.77 | 20.19 | 20.77 | 21.19 | 21.77 | 22.19 | 22.77 |
| Camarilla | 21.07 | 21.16 | 21.25 | 21.34 | 21.43 | 21.52 | 21.62 |
| Woodie | 19.84 | 20.23 | 20.84 | 21.23 | 21.84 | 22.23 | 22.84 |
| Fibonacci | 20.19 | 20.58 | 20.81 | 21.19 | 21.58 | 21.81 | 22.19 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 12.40 | 14.90 | 17.63 | 20.13 | 22.86 | 25.36 | 28.09 |
| Camarilla | 18.92 | 19.40 | 19.88 | 20.36 | 20.84 | 21.32 | 21.80 |
| Woodie | 12.52 | 14.96 | 17.75 | 20.19 | 22.98 | 25.42 | 28.21 |
| Fibonacci | 14.90 | 16.90 | 18.13 | 20.13 | 22.13 | 23.36 | 25.36 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 10.55 | 12.66 | 14.72 | 16.83 | 18.89 | 21.00 | 23.06 |
| Camarilla | 15.63 | 16.02 | 16.40 | 16.78 | 17.16 | 17.55 | 17.93 |
| Woodie | 10.53 | 12.65 | 14.70 | 16.82 | 18.87 | 20.99 | 23.04 |
| Fibonacci | 12.66 | 14.25 | 15.24 | 16.83 | 18.42 | 19.41 | 21.00 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 64.30 | |
| MACD (12,26,9): | 0.4700 | |
| Directional Movement: | 12.37 | |
| AROON (14): | 78.57 | |
| DEMA (21): | 21.40 | |
| Parabolic SAR (0,02-0,02-0,2): | 19.27 | |
| Elder Ray (13): | 0.34 | |
| Super Trend (3,10): | 19.82 | |
| Zig ZAG (10): | 21.64 | |
| VORTEX (21): | 1.1800 | |
| Stochastique (14,3,5): | 86.73 | |
| TEMA (21): | 21.52 | |
| Williams %R (14): | -1.72 | |
| Chande Momentum Oscillator (20): | 1.56 | |
| Repulse (5,40,3): | 2.5500 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | 0.3200 | |
| Courbe Coppock: | 9.83 |
| MA7: | 20.54 | |
| MA20: | 18.80 | |
| MA50: | 17.20 | |
| MA100: | 21.29 | |
| MAexp7: | 21.33 | |
| MAexp20: | 20.95 | |
| MAexp50: | 20.01 | |
| MAexp100: | 19.21 | |
| Price / MA7: | +6.82% | |
| Price / MA20: | +16.70% | |
| Price / MA50: | +27.56% | |
| Price / MA100: | +3.05% | |
| Price / MAexp7: | +2.86% | |
| Price / MAexp20: | +4.73% | |
| Price / MAexp50: | +9.65% | |
| Price / MAexp100: | +14.21% |
Quotes :
-
15 min delayed data
-
Actions NASDAQ
News
The last news published on ABCELLERA BIOLOGICS INC. at the time of the generation of this analysis was as follows:
- AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody Therapies
- Lilly to Supply the EU and EEA with up to 220,000 Doses of AbCellera-Discovered Bamlanivimab Together with Etesevimab for the Treatment of Confirmed COVID-19
- Emergency Use Authorization of AbCellera-Discovered Bamlanivimab Administered with Etesevimab Expanded by the FDA to Include Post-Exposure Prophylaxis for the Prevention of COVID-19
- AbCellera Announces Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines
- AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets